Johns Hopkins researchers develop patient-derived 'mini-brains' for Alzheimer's modeling

Researchers have successfully cultured organoid 'mini-brains' using cells from Alzheimer's patients to simulate disease progression. This methodology provides a platform for studying regional brain impact and personalized drug response, though clinical efficacy remains to be validated.